157 related articles for article (PubMed ID: 20938784)
1. The expression and distribution of group IIA phospholipase A2 in human colorectal tumours.
Avoranta T; Sundström J; Korkeila E; Syrjänen K; Pyrhönen S; Laine J
Virchows Arch; 2010 Dec; 457(6):659-67. PubMed ID: 20938784
[TBL] [Abstract][Full Text] [Related]
2. Group IIA phospholipase A as a prognostic marker in prostate cancer: relevance to clinicopathological variables and disease-specific mortality.
Mirtti T; Laine VJ; Hiekkanen H; Hurme S; Rowe O; Nevalainen TJ; Kallajoki M; Alanen K
APMIS; 2009 Mar; 117(3):151-61. PubMed ID: 19245588
[TBL] [Abstract][Full Text] [Related]
3. Effects of expression of hRFI on adenoma formation and tumor progression in colorectal adenoma-carcinoma sequence.
Sasaki S; Watanabe T; Konishi T; Kitayama J; Nagawa H
J Exp Clin Cancer Res; 2004 Sep; 23(3):507-12. PubMed ID: 15595643
[TBL] [Abstract][Full Text] [Related]
4. Secretory component mRNA and protein expression in colorectal adenomas and carcinomas.
Krajci P; Meling GI; Andersen SN; Hofstad B; Vatn MH; Rognum TO; Brandtzaeg P
Br J Cancer; 1996 Jun; 73(12):1503-10. PubMed ID: 8664120
[TBL] [Abstract][Full Text] [Related]
5. Cellular localization of group IIA phospholipase A2 in rats.
Yoshikawa T; Naruse S; Kitagawa M; Ishiguro H; Nagahama M; Yasuda E; Semba R; Tanaka M; Nomura K; Hayakawa T
J Histochem Cytochem; 2001 Jun; 49(6):777-82. PubMed ID: 11373324
[TBL] [Abstract][Full Text] [Related]
6. Expression of transcription factor AP-2 in colorectal adenomas and adenocarcinomas; comparison of immunohistochemistry and in situ hybridisation.
Ropponen KM; Kellokoski JK; Pirinen RT; Moisio KI; Eskelinen MJ; Alhava EM; Kosma VM
J Clin Pathol; 2001 Jul; 54(7):533-8. PubMed ID: 11429425
[TBL] [Abstract][Full Text] [Related]
7. p53 expression patterns in colorectal adenomas and early carcinomas: a special reference to depressed adenoma and non-polypoid carcinoma.
Yao T; Utsunomiya T; Nagai E; Oya M; Tsuneyoshi M
Pathol Int; 1996 Dec; 46(12):962-7. PubMed ID: 9110348
[TBL] [Abstract][Full Text] [Related]
8. PLA2 (group IIA phospholipase A2) as a prognostic determinant in stage II colorectal carcinoma.
Buhmeida A; Bendardaf R; Hilska M; Laine J; Collan Y; Laato M; Syrjänen K; Pyrhönen S
Ann Oncol; 2009 Jul; 20(7):1230-5. PubMed ID: 19276398
[TBL] [Abstract][Full Text] [Related]
9. Elevated expression of Bcl-X and reduced Bak in primary colorectal adenocarcinomas.
Krajewska M; Moss SF; Krajewski S; Song K; Holt PR; Reed JC
Cancer Res; 1996 May; 56(10):2422-7. PubMed ID: 8625322
[TBL] [Abstract][Full Text] [Related]
10. Expression of MUC1 and MUC2 mucins and relationship with cell proliferative activity in human colorectal neoplasia.
Li A; Goto M; Horinouchi M; Tanaka S; Imai K; Kim YS; Sato E; Yonezawa S
Pathol Int; 2001 Nov; 51(11):853-60. PubMed ID: 11844051
[TBL] [Abstract][Full Text] [Related]
11. Group II subfamily secretory phospholipase A2 enzymes: expression in chronic rhinosinusitis with and without nasal polyps.
Liu Z; Lu X; Wang H; You XJ; Gao QX; Cui YH
Allergy; 2007 Sep; 62(9):999-1006. PubMed ID: 17578498
[TBL] [Abstract][Full Text] [Related]
12. Clusterin expression is associated with decreased disease-free survival of patients with colorectal carcinomas.
Redondo M; Rodrigo I; Alcaide J; Tellez T; Roldan MJ; Funez R; Diaz-Martin A; Rueda A; Jiménez E
Histopathology; 2010 Jun; 56(7):932-6. PubMed ID: 20497247
[TBL] [Abstract][Full Text] [Related]
13. Lumican and versican protein expression are associated with colorectal adenoma-to-carcinoma progression.
de Wit M; Carvalho B; Delis-van Diemen PM; van Alphen C; Beliën JAM; Meijer GA; Fijneman RJA
PLoS One; 2017; 12(5):e0174768. PubMed ID: 28481899
[TBL] [Abstract][Full Text] [Related]
14. Mucins in the colorectal neoplastic spectrum with reference to conventional and serrated adenomas.
Perçinel S; Savaş B; Ensari A; Kuzu I; Kuzu MA; Bektaş M; Cetinkaya H; Kurşun N
Turk J Gastroenterol; 2007 Dec; 18(4):230-8. PubMed ID: 18080919
[TBL] [Abstract][Full Text] [Related]
15. Proliferation and apoptosis in proliferative lesions of the colon and rectum.
Kikuchi Y; Dinjens WN; Bosman FT
Virchows Arch; 1997 Aug; 431(2):111-7. PubMed ID: 9293892
[TBL] [Abstract][Full Text] [Related]
16. Epithelial and stromal genetic instability contributes to genesis of colorectal adenomas.
Ishiguro K; Yoshida T; Yagishita H; Numata Y; Okayasu T
Gut; 2006 May; 55(5):695-702. PubMed ID: 16354798
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical expression of bcl-2 and p53 oncoproteins: correlation with Ki67 proliferation index and prognostic histopathologic parameters in colorectal neoplasia.
Saleh HA; Jackson H; Banerjee M
Appl Immunohistochem Mol Morphol; 2000 Sep; 8(3):175-82. PubMed ID: 10981868
[TBL] [Abstract][Full Text] [Related]
18. The ratio of Matriptase/HAI-1 mRNA is higher in colorectal cancer adenomas and carcinomas than corresponding tissue from control individuals.
Vogel LK; Saebø M; Skjelbred CF; Abell K; Pedersen ED; Vogel U; Kure EH
BMC Cancer; 2006 Jul; 6():176. PubMed ID: 16820046
[TBL] [Abstract][Full Text] [Related]
19. Expression of group XIIA phospholipase A2 in human digestive organs.
Peuravuori H; Kollanus S; Nevalainen TJ
APMIS; 2014 Dec; 122(12):1171-7. PubMed ID: 24862647
[TBL] [Abstract][Full Text] [Related]
20. Expression of Bcl-2 and p53 in the colorectal adenoma-carcinoma sequence.
Hao XP; Ilyas M; Talbot IC
Pathobiology; 1997; 65(3):140-5. PubMed ID: 9309780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
